Your search returned 5 results.

Results
	1.	Dasatinib-induced pulmonary arterial hypertension unresponsive to PDE-5 inhibition. [electronic resource] by Groeneveldt, Joanne A Gans, Steven J M Bogaard, Harm J Vonk-Noordegraaf, Anton Producer: 20140325 In: The European respiratory journal vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study. [electronic resource] by Vogelmeier, Claus Kardos, Peter Harari, Sergio Gans, Steven J M Stenglein, Stephan Thirlwell, Jackie Producer: 20090105 In: Respiratory medicine vol. 102 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: a risk-benefit analysis of a large phase III study. [electronic resource] by Scagliotti, Giorgio V Park, Keunchil Patil, Shekar Rolski, Janusz Goksel, Tuncay Martins, Renato Gans, Steven J M Visseren-Grul, Carla Peterson, Patrick Producer: 20090915 In: European journal of cancer (Oxford, England : 1990) vol. 45 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Successful treatment of azole-resistant invasive aspergillosis in a bottlenose dolphin with high-dose posaconazole. [electronic resource] by Bunskoek, Paulien E Seyedmousavi, Seyedmojtaba Gans, Steven J M van Vierzen, Peter B J Melchers, Willem J G van Elk, Cornelis E Mouton, Johan W Verweij, Paul E Publication details: Medical mycology case reports Jun 2017 In: Medical mycology case reports vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study. [electronic resource] by Buikhuisen, Wieneke A Burgers, Jacobus A Vincent, Andrew D Korse, Catharina M van Klaveren, Rob J Schramel, Franz M N H Pavlakis, Nick Nowak, Anna K Custers, Frank L J Schouwink, J Hugo Gans, Steven J M Groen, Harry J M Strankinga, Wim F M Baas, Paul Producer: 20130628 In: The Lancet. Oncology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)